University Bridge Fund I

CroiValve Limited, founded in 2016 and based in Dublin, Ireland, specializes in the development of a medical device aimed at treating severe tricuspid regurgitation through a minimally invasive procedure. The company's innovative device allows for percutaneous delivery via a vein into the right heart, effectively sealing the gap between the native tricuspid valve leaflets. This approach restores proper valve function and prevents regurgitation, enabling healthcare professionals to address this condition in a safe, effective, and cost-efficient manner. CroiValve's solution is designed to be user-friendly, catering to a broad range of patients suffering from this serious heart issue.

PlasmaBound Ltd. is a Dublin-based company that specializes in advanced surface treatment technologies for fibre-reinforced composites. Established in 2017, PlasmaBound develops a proprietary method known as Controlled Plasma Ablation (CPA). This innovative technology modifies atmospheric plasma to enhance the bonding of lightweight materials, specifically carbon and glass fibre composites, allowing for strong and resilient adhesive joins. By facilitating reliable structural adhesive joining, PlasmaBound’s solutions significantly reduce the payload of heavy assemblies and improve reject rates in manufacturing processes. The company's services cater to various industries, including aerospace, transportation, marine, renewable energy, and consumer electronics, promoting the wider adoption of lightweight composite materials in multi-material structural assemblies.

CroiValve Limited, founded in 2016 and based in Dublin, Ireland, specializes in the development of a medical device aimed at treating severe tricuspid regurgitation through a minimally invasive procedure. The company's innovative device allows for percutaneous delivery via a vein into the right heart, effectively sealing the gap between the native tricuspid valve leaflets. This approach restores proper valve function and prevents regurgitation, enabling healthcare professionals to address this condition in a safe, effective, and cost-efficient manner. CroiValve's solution is designed to be user-friendly, catering to a broad range of patients suffering from this serious heart issue.

ProVerum Medical is a medtech company focused on developing innovative minimally invasive devices for the treatment of benign prostatic hyperplasia (BPH). The company's technology offers a safer and more patient-friendly alternative to traditional BPH treatments, allowing patients to receive care in either a doctor's office or an operating room. ProVerum's device is designed to address the symptoms of prostate enlargement, which can lead to difficulties in urination. By placing the device inside the urethra, it aims to restore normal urinary function, ultimately enabling healthcare providers to deliver effective treatment options for patients suffering from this condition.

Tympany Medical is a company focused on advancing minimally invasive ear surgeries through innovative technology. It has developed a specialized ear surgery device that facilitates sterile endoscopy in the field of otolaryngology. This device addresses the challenges associated with traditional endoscopes, enhancing usability and flexibility for surgeons. By enabling effective endoscopic visualization, Tympany's technology allows surgeons to perform complex ear procedures while preserving their two-handed operating technique. The company's mission is to reduce the need for unnecessary mastoidectomies and improve surgical outcomes for patients undergoing ear surgery.

LUMA Vision is a company focused on developing connected intra-vascular medical devices to enhance the treatment of cardiac arrhythmias. Utilizing advanced four-dimensional imaging and artificial intelligence, LUMA Vision improves the efficacy of electrophysiology (EP) and structural heart interventions. The company's innovative approach enables healthcare professionals to conduct cardiac procedures that lead to better patient outcomes, increased procedural safety, and lower costs for the healthcare system. Through real-time tissue analysis, LUMA Vision is poised to transform how cardiac treatments are performed, ultimately benefiting both patients and healthcare providers.

TerminusDB is a Dublin-based company that specializes in providing an open-source, full-featured in-memory graph database management system. Its platform is designed to transform inconsistent data sets into structured and integrated data, utilizing a rich query language known as WOQL. TerminusDB offers comprehensive revision control features, including branching, merging, and time-travel capabilities, which enhance data management and decision-making processes. The platform is aimed at helping users infer data from business objects and relationships, define governing rules, and automate the migration of relevant data for analytics. By focusing on data structuring to meet business needs, TerminusDB enables organizations to improve productivity and optimize efficiency.

Parvalis Therapeutics is a biotechnology company based in Dublin, Ireland, focused on developing innovative therapies for autoimmune disorders and cancer. Established in 2020, the company specializes in creating novel immunotherapeutics and conducts research on immunomodulatory compounds. Through its efforts, Parvalis aims to provide effective treatments for patients suffering from inflammatory diseases, enhancing the options available to both patients and healthcare professionals.

PlasmaBound Ltd. is a Dublin-based company that specializes in advanced surface treatment technologies for fibre-reinforced composites. Established in 2017, PlasmaBound develops a proprietary method known as Controlled Plasma Ablation (CPA). This innovative technology modifies atmospheric plasma to enhance the bonding of lightweight materials, specifically carbon and glass fibre composites, allowing for strong and resilient adhesive joins. By facilitating reliable structural adhesive joining, PlasmaBound’s solutions significantly reduce the payload of heavy assemblies and improve reject rates in manufacturing processes. The company's services cater to various industries, including aerospace, transportation, marine, renewable energy, and consumer electronics, promoting the wider adoption of lightweight composite materials in multi-material structural assemblies.

LUMA Vision is a company focused on developing connected intra-vascular medical devices to enhance the treatment of cardiac arrhythmias. Utilizing advanced four-dimensional imaging and artificial intelligence, LUMA Vision improves the efficacy of electrophysiology (EP) and structural heart interventions. The company's innovative approach enables healthcare professionals to conduct cardiac procedures that lead to better patient outcomes, increased procedural safety, and lower costs for the healthcare system. Through real-time tissue analysis, LUMA Vision is poised to transform how cardiac treatments are performed, ultimately benefiting both patients and healthcare providers.

Output Sports Limited is a sports technology company based in Dublin, Ireland, established in 2018. The company specializes in developing wearable sensors aimed at optimizing athlete performance. By employing advanced signal processing and machine learning techniques, Output Sports has created an innovative end-to-end solution that assesses various components of athletic performance and monitors training programs using a single wearable device. This tool not only evaluates an athlete's readiness to train but also delivers training biofeedback and facilitates injury management. As a result, sports practitioners can enhance athlete performance with improved portability, practicality, and accuracy.

AYLIEN is a Delaware-based tech company specializing in artificial intelligence and machine learning solutions for natural language processing. It offers a suite of tools, including Talk.ee for information collection and categorization, Talk.ee News Ticker for real-time news updates, and AYLIEN App Engine for developing micro-applications. These tools enable users to extract meaning and insights from large volumes of human-generated content, catering to developers, data scientists, marketers, and academics. Additionally, AYLIEN provides oTaste, a tool for digitizing human tastes.

AtriAN Medical is an Irish medical device company based in Galway, a prominent center for medical technology innovation. The company is focused on commercializing advanced technology developed at the Mayo Clinic in the United States. AtriAN specializes in a medical device designed to treat atrial fibrillation by employing micro Pulsed Electric Fields (mPEF). This innovative approach selectively ablates hyperactive tissue while preserving surrounding myocardium, minimizing damage to the heart muscle. Utilizing a catheter, AtriAN's device delivers short pulses of electrical energy directly to the problematic areas, offering a targeted treatment option that enhances patient safety and outcomes.

CroiValve Limited, founded in 2016 and based in Dublin, Ireland, specializes in the development of a medical device aimed at treating severe tricuspid regurgitation through a minimally invasive procedure. The company's innovative device allows for percutaneous delivery via a vein into the right heart, effectively sealing the gap between the native tricuspid valve leaflets. This approach restores proper valve function and prevents regurgitation, enabling healthcare professionals to address this condition in a safe, effective, and cost-efficient manner. CroiValve's solution is designed to be user-friendly, catering to a broad range of patients suffering from this serious heart issue.

Pharma Latch, a division of Latch Medical, specializes in innovative drug and vaccine delivery systems, focusing on intradermal administration. The company has developed a unique tissue anchor system that employs micro-needle technology, featuring angled microneedles designed to painlessly penetrate the outer layers of the skin. This method not only enhances the patient experience but also ensures consistent needle penetration for effective delivery. By leveraging its core platform technology, Pharma Latch provides healthcare professionals with improved alternatives to traditional wound stitching, unlocking the potential of various drugs and vaccines in a more efficient manner.

CroiValve Limited, founded in 2016 and based in Dublin, Ireland, specializes in the development of a medical device aimed at treating severe tricuspid regurgitation through a minimally invasive procedure. The company's innovative device allows for percutaneous delivery via a vein into the right heart, effectively sealing the gap between the native tricuspid valve leaflets. This approach restores proper valve function and prevents regurgitation, enabling healthcare professionals to address this condition in a safe, effective, and cost-efficient manner. CroiValve's solution is designed to be user-friendly, catering to a broad range of patients suffering from this serious heart issue.

Danalto Limited is a Dublin-based company that develops and manufactures innovative Internet of Things (IoT) solutions and services. Founded in 2017, Danalto provides a range of devices and managed services tailored for business enterprises, including d-IoT, a comprehensive solution that enhances operational and energy efficiency through the deployment of sensor devices. These sensors monitor various parameters such as temperature, humidity, and liquid levels, facilitating custom insights for clients across sectors like agriculture, facilities management, and utilities. Notable products include d-AlignSpy, which monitors communication links in network infrastructures, and d-GullySpy, designed for flood detection in urban environments. Danalto's platform integrates diverse tracking capabilities and offers high-accuracy positioning intelligence, allowing for effective asset management in both indoor and outdoor settings while minimizing infrastructure needs and operational costs.

Kastus is an award-winning surface innovation company based in Ireland, founded in 2014 by John Browne after over a decade of research and development. The company specializes in patented antiviral and antibacterial surface coatings designed to enhance hygiene on various surfaces, particularly glass and ceramics. Kastus' technology has been validated by ISO standards and proven to kill over 99% of harmful bacteria, viruses, fungi, and antibiotic-resistant superbugs, including human coronavirus. This makes it highly effective for products that require continuous touch hygiene. In response to the COVID-19 pandemic, Kastus launched antiviral and antimicrobial screen protectors to help businesses reopen safely. The company has also received EU funding for developing innovative solutions to combat Covid-19.

Coras is a technology company that specializes in facilitating ancillary revenue for major airlines such as Ryanair, Lufthansa, Wizz Air, and Air Asia. Operating in over 50 countries, 350 cities, and supporting 20 languages and currencies, Coras has expanded its services to include Fidaapp.io, a web3 loyalty platform. This platform enables tokenized commerce, allowing customers to spend their loyalty points across multiple brand partners, thereby enhancing the value of loyalty programs for both consumers and businesses.

TerminusDB is a Dublin-based company that specializes in providing an open-source, full-featured in-memory graph database management system. Its platform is designed to transform inconsistent data sets into structured and integrated data, utilizing a rich query language known as WOQL. TerminusDB offers comprehensive revision control features, including branching, merging, and time-travel capabilities, which enhance data management and decision-making processes. The platform is aimed at helping users infer data from business objects and relationships, define governing rules, and automate the migration of relevant data for analytics. By focusing on data structuring to meet business needs, TerminusDB enables organizations to improve productivity and optimize efficiency.

Volograms Limited is a Dublin-based company that specializes in volumetric video processing, transforming 2D videos into immersive volumetric holograms. Founded in 2018, Volograms has developed a mobile content creation platform called Volu, which utilizes artificial intelligence to enable users to generate 3D content for augmented reality applications. This innovative technology allows smartphone users to create, share, and interact with dynamic content from a simple video, catering to various use cases, including digital productions, fan engagement, and enterprise training. Volograms aims to democratize access to advanced content creation tools, making immersive communications accessible to a broader audience.

ProVerum Medical is a medtech company focused on developing innovative minimally invasive devices for the treatment of benign prostatic hyperplasia (BPH). The company's technology offers a safer and more patient-friendly alternative to traditional BPH treatments, allowing patients to receive care in either a doctor's office or an operating room. ProVerum's device is designed to address the symptoms of prostate enlargement, which can lead to difficulties in urination. By placing the device inside the urethra, it aims to restore normal urinary function, ultimately enabling healthcare providers to deliver effective treatment options for patients suffering from this condition.

Siren is an investigative intelligence platform that integrates data from various sources, including open, vendor, and classified information, to enhance analysis in fields such as National Security, Public Safety, Fraud and Compliance, and Cyber Threats. The company utilizes artificial intelligence and patented technology to offer a user-friendly interface for search, analytics, visualization, and reporting across diverse data types and volumes. Siren's platform supports advanced features such as temporal analysis, full-text search, and scientific visualizations, enabling organizations to strengthen their data investigation and analytical capabilities. In recognition of its innovative approach, Siren was included in the Deloitte Technology Fast 50 in November 2022 and was named a Gartner Cool Vendor in an Analytics and Data Science Report in 2020.

iheed is an online medical education company that designs, develops, and delivers online accredited post-graduate education programs and degrees in partnership with medical universities. The company is built by doctors and healthcare professionals (HCPs) for doctors and healthcare professionals. iheed offers certificate, diploma, and Masters level education material to HCPs, packaged in modules. It utilizes technologies to offer the students a personalized, multi-sensory, multi-device learning experience suited to their learning style. Its programs and courses are adapted to the requirements of the healthcare system in different countries combining global best practice in medical training with local population healthcare needs. Its programs and courses are aimed at addressing the broad topics of healthcare need for frontline HCPs globally such as diabetes, women’s health, neurodegenerative diseases, cardiology, travel medicine, infection control, emergency medicine, disaster planning, research methodologies, practice management, nursing and pharmacology, and more. The iheed Online Learning Environment (OLE) is a next generation cloud-based platform for online education supports interactive case-based learning methods, provides practical real-world education for practicing clinicians, and helps them build up their clinical, professional, and communication skills in patient consultation. It offers a number of features aimed at tutors and administrators such as rubrics, Speedgrader, and Turnitin to support tutors in reviewing and grading student assignments, extensive reporting and analytics, targeted messaging, and various views that enable tutors to identify students that are not keeping up with the instruction or meeting pre-defined learning thresholds. Tutors of iheed’s Tutor Network hold weekly, bi-monthly, and per topic tutorial discussions via the web conferencing system within the iheed OLE platform to ensure students are aware of what is expected of them each week, and to discuss the key learning points in the context of the students’ day-to-day practices. iheed works in partnership with many medical universities, global health organizations, and technology companies, including University of Florida Health, Qualcomm, Hamad International Training Center, Johnson & Johnson, Health Human Resources Development Center, HP, Harvard School of Public Health, Tropical Medical Bureau, and Alliance Boots. Iheed was founded in 2010 and is based in Dublin, Ireland.

AYLIEN is a Delaware-based tech company specializing in artificial intelligence and machine learning solutions for natural language processing. It offers a suite of tools, including Talk.ee for information collection and categorization, Talk.ee News Ticker for real-time news updates, and AYLIEN App Engine for developing micro-applications. These tools enable users to extract meaning and insights from large volumes of human-generated content, catering to developers, data scientists, marketers, and academics. Additionally, AYLIEN provides oTaste, a tool for digitizing human tastes.

Coras is a technology company that specializes in facilitating ancillary revenue for major airlines such as Ryanair, Lufthansa, Wizz Air, and Air Asia. Operating in over 50 countries, 350 cities, and supporting 20 languages and currencies, Coras has expanded its services to include Fidaapp.io, a web3 loyalty platform. This platform enables tokenized commerce, allowing customers to spend their loyalty points across multiple brand partners, thereby enhancing the value of loyalty programs for both consumers and businesses.

Ambisense Ltd. is a Dublin-based company that specializes in the design and manufacture of gas monitoring instruments and networks for the Internet of Things (IoT) market. Founded in 2008, Ambisense has been at the forefront of innovation in the environmental sector since 2014. The company’s technology platform, known as Ambilytics, integrates IoT and machine learning solutions to optimize environmental risk assessments for major infrastructure projects across various industries, including industrial, oil and gas, and waste management. By combining data from remotely deployed field devices with contextual information such as weather and operational data, Ambisense develops machine learning models that uncover hidden relationships and patterns within the data. This enables clients to forecast and predict the behavior of environmental pollutants effectively.

Siren is an investigative intelligence platform that integrates data from various sources, including open, vendor, and classified information, to enhance analysis in fields such as National Security, Public Safety, Fraud and Compliance, and Cyber Threats. The company utilizes artificial intelligence and patented technology to offer a user-friendly interface for search, analytics, visualization, and reporting across diverse data types and volumes. Siren's platform supports advanced features such as temporal analysis, full-text search, and scientific visualizations, enabling organizations to strengthen their data investigation and analytical capabilities. In recognition of its innovative approach, Siren was included in the Deloitte Technology Fast 50 in November 2022 and was named a Gartner Cool Vendor in an Analytics and Data Science Report in 2020.

Petronics is a company that develops robotic pets specifically designed for cats. Founded in 2014 and based in Champaign, Illinois, it offers a flagship product called Mousr, a robotic toy that features 360-degree vision, environmental sensing, and Bluetooth connectivity. These innovative products aim to engage indoor cats in play that mimics hunting behavior, promoting physical activity and helping to reduce obesity in pets. Through its advanced technology, Petronics seeks to enhance the interaction between cats and their owners while providing a stimulating environment for feline companions.

Kastus is an award-winning surface innovation company based in Ireland, founded in 2014 by John Browne after over a decade of research and development. The company specializes in patented antiviral and antibacterial surface coatings designed to enhance hygiene on various surfaces, particularly glass and ceramics. Kastus' technology has been validated by ISO standards and proven to kill over 99% of harmful bacteria, viruses, fungi, and antibiotic-resistant superbugs, including human coronavirus. This makes it highly effective for products that require continuous touch hygiene. In response to the COVID-19 pandemic, Kastus launched antiviral and antimicrobial screen protectors to help businesses reopen safely. The company has also received EU funding for developing innovative solutions to combat Covid-19.

ProVerum Medical is a medtech company focused on developing innovative minimally invasive devices for the treatment of benign prostatic hyperplasia (BPH). The company's technology offers a safer and more patient-friendly alternative to traditional BPH treatments, allowing patients to receive care in either a doctor's office or an operating room. ProVerum's device is designed to address the symptoms of prostate enlargement, which can lead to difficulties in urination. By placing the device inside the urethra, it aims to restore normal urinary function, ultimately enabling healthcare providers to deliver effective treatment options for patients suffering from this condition.